IGSF9 promotes immunotherapy resistance in colon cancer by orchestrating an immunosuppressive tumor microenvironment and enables combinatorial targeting strategies

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC12914246 | biostudies-literature | 2026 Feb

REPOSITORIES: biostudies-literature